Sugi Predict

Sugi Predict / Compounds / Pyrophosphoric Acid

Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL184652

O=P(O)(O)OP(=O)(O)O.[CaH2].[NaH]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 1/20 0.83
▸ BLM P54132 1/20 0.83
▸ TDP1 Q9NUW8 1/20 0.83
▸ CA4 P22748 1/20 0.35
▸ INPPL1 O15357 2/20 0.33
▸ INPP5A Q14642 2/20 0.33
▸ BTN3A1 O00481 2/20 0.33
▸ SMPD1 P17405 1/20 0.33
▸ INPP5B P32019 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ ITPR3 Q14573 3/20 0.32
▸ ITPR2 Q14571 1/20 0.32
▸ ITPR1 Q14643 1/20 0.32
▸ SLC34A1 Q06495 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL4064450 1.00 FDPS (0.83) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL27887225 1.00 FDPS (0.83) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL28080419 1.00 FDPS (0.83) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL11779427 1.00 FDPS (0.83) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL18704841 1.00 FDPS (0.83) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL28831973 0.96 FDPS (0.77) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL10340101 0.96 FDPS (0.77) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL29053870 0.96 FDPS (0.77) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL11779402 0.96 FDPS (0.77) FDPSBLMTDP1CA4INPPL1
Pyrophosphoric Acid SCHEMBL27910912 0.96 FDPS (0.77) FDPSBLMTDP1CA4INPPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 753 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260090966-A1 UROLITHIN COMPOSITIONS AMAZENTIS SA (CH) 2026-04-02 — — US claimed
CN-119943952-A Positive electrode material, positive electrode plate, battery cell, sodium ion battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-05-06 — — CN claimed
US-12193868-B2 Breast calcification imaging phantoms and methods of use THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2025-01-14 — — US claimed
EP-2934694-B1 ANTI-PLAQUE ORAL COMPOSITIONS BHUSHAN RAJIV (US) 2023-06-28 — — EP claimed
US-20220401057-A1 Breast Calcification Imaging Phantoms and Methods of Use THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2022-12-22 — — US claimed
US-10702463-B2 Oral compositions for anticavity and desensitization use THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-07-07 — — US claimed
EP-2432444-B1 ORAL COMPOSITIONS CONTAINING POLYGUANIDINIUM COMPOUNDS AND METHODS OF MANUFACTURE AND USE THEREOF COLGATE PALMOLIVE CO (US) 2017-08-23 — — EP claimed
US-20160279042-A1 Dental Anti-Hypersensitivity Composition and Method THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2016-09-29 — — US claimed
CN-105412143-A Oral cavity composition containing polyguanidine compounds and preparation and application method of oral cavity composition COLGATE PALMOLIVE CO 2016-03-23 — — CN claimed
US-20150335557-A1 ANTI-PLAQUE ORAL COMPOSITIONS BHUSNAN RAJIV (US) 2015-11-26 — — US claimed
US-6524558-B2 For calcifying dental tissue, e.g., preventing or treating dental hypersensitivity THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK 2003-02-25 — — US claimed
US-20030017209-A1 Breath protection microcapsules WARNER-LAMBERT COMPANY 2003-01-23 — — US claimed
US-6436370-B1 ORAL COMPOSITION OF ARGININE BICARBONATE AND CALCIUM CARBONATE PROMOTES THE FORMATION OF DENTINAL TUBULE PLUGS AIDED BY COMBINING CALCIUM AND PHOSPHATE IN THE FLUID THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-08-20 — — US claimed
US-20020068039-A1 Oral care compositions containing grapefruit seed extract PAN PAULINE C (US) 2002-06-06 — — US claimed
US-20020064504-A1 Dental anti-hypersensitivity composition and method THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-05-30 — — US claimed
US-6375459-B1 Apparatus and method for cleaning teeth DEKA PRODUCTS LIMITED PARTNERSHIP 2002-04-23 — — US claimed
EP-1187593-A1 DENTAL ANTI-HYPERSENSITIVITY COMPOSITION AND METHOD The Research Foundation of State University of New York (US) 2002-03-20 — — EP claimed
WO-2002011641-A2 APPARATUS AND METHOD FOR CLEANING TEETH DEKA PRODUCTS LIMITED PARTNERSHIP (US) 2002-02-14 — — WO claimed
WO-2000078270-A1 DENTAL ANTI-HYPERSENSITIVITY COMPOSITION AND METHOD THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2000-12-28 — — WO claimed
US-3985675-A PARTIALLY DEHYDRATED AMORPHOUS CALCIUM SODIUM PYROPHOSPHATE MONSANTO COMPANY (US) 1976-10-12 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090966-A1 UROLITHIN COMPOSITIONS UTS2R, TAS2R30, TAS2R42 FDPS 2913/4885BLM 3023/4885TDP1 454/4885
US-20030017209-A1 Breath protection microcapsules MLYCD, SCD5, FBP1 FDPS 43/4885BLM 1083/4885TDP1 4505/4885
US-20150335557-A1 ANTI-PLAQUE ORAL COMPOSITIONS MGMT, CAPG, TRPM7 FDPS 1807/4885BLM 1795/4885TDP1 2208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.